Eyebright Medical Technology (Beijing) Balance Sheet Health
Financial Health criteria checks 5/6
Eyebright Medical Technology (Beijing) has a total shareholder equity of CN¥2.5B and total debt of CN¥733.7M, which brings its debt-to-equity ratio to 29.6%. Its total assets and total liabilities are CN¥3.4B and CN¥946.5M respectively. Eyebright Medical Technology (Beijing)'s EBIT is CN¥379.8M making its interest coverage ratio 146. It has cash and short-term investments of CN¥622.8M.
Key information
29.6%
Debt to equity ratio
CN¥733.70m
Debt
| Interest coverage ratio | 146x |
| Cash | CN¥622.82m |
| Equity | CN¥2.48b |
| Total liabilities | CN¥946.53m |
| Total assets | CN¥3.43b |
Recent financial health updates
Recent updates
Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 23
Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)
Jul 15Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings
Jun 10Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01Financial Position Analysis
Short Term Liabilities: 688050's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥322.0M).
Long Term Liabilities: 688050's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥624.5M).
Debt to Equity History and Analysis
Debt Level: 688050's net debt to equity ratio (4.5%) is considered satisfactory.
Reducing Debt: 688050's debt to equity ratio has increased from 0.5% to 29.6% over the past 5 years.
Debt Coverage: 688050's debt is well covered by operating cash flow (34.7%).
Interest Coverage: 688050's interest payments on its debt are well covered by EBIT (146x coverage).